June 27, 2019 ELab Due Diligence

John Bradley, Torreya Partners

Alan Wink, EisnerAmper, John Bradley, Torreya Partners, Matt McCambridge, Eden Health and Alan Shaw, Sirnaomics

Alan Wink, EisnerAmper

John Bradley, Torreya Partners

Matt McCambridge, Eden Health

Alan Roemer, Roivant Sciences

Dennis Purcell, Aisling Capital

John Pennett, EisnerAmper

Yaniv Sneor, MABA

Barry Kappel, Sapience Therapeutics

Meghan Cross Breeden, AmplifyHer Ventures

Sophia Cacciatore, NYCEDC

Michael Osso, Crohn's & Colitis Foundation's, Sophia Cacciatore, NYCEDC and Jason Campbell, Global Symmetry

Philip Glick, Conner Strong, Phil Bergamo, EisnerAmper and Scott Matarese, Willis Towers Watson

Scott Matarese, Willis Towers Watson

Philip Glick, Conner Strong

Mary Howard, ElabNYC | ABCT

Jason Campbell, Global Symmetry

Michael Osso, Crohn's & Colitis Foundation's

Abby Robberts, Merril Corporation

Philip Glick, Conner Strong

Phil Bergamo, EisnerAmper

Scott Matarese, Willis Towers Watson

Craig Kenesky, WSGR

Sue Crinnion, JP Morgan Chase

Michael Baran, Pfizer Ventures

Evan Myrianthopoulos, GPB Capital

Chris Barnstable-Brown ,WilmerHale

Sue Crinnion, JP Morgan Chase

Sundeep Bhan, Prognos

Thjis Spoor, AzurX BioPharma

John Pennet, EisnerAmper

Amit Bansal, Digitalis Ventures, Fiona Mack, Roche and Steve O'Loughlin, Actinium Pharmaceuticals

Steve O'Loughlin, Actinium Pharmaceuticals

Fiona Mack, Roche

Amit Bansal, Digitalis Ventures

Fiona Mack, Roche

Muriel Liberto, Mintz

Muriel Liberto, Mintz, Amit Bansal, Digitalis Ventures, Fiona Mack, Roche and Steve O'Loughlin, Actinium Pharmaceuticals

Steve O'Loughlin, Actinium Pharmaceuticals

Preparing for Due Diligence workshop, 6.27.19

Mary Howard, ElabNYC | ABCT

John Pennett, EisnerAmper

Krista Fretes, Gentroma

Rotem Lev-Zwickel, Agamon and Matt McCambridge, Eden Health

Alan Wink, EisnerAmper and Mary Howard, ElabNYC | ABCT

Mary Howard, ElabNYC | ABCT and Matt McCambridge, Eden Health

Omar Green, Ionica Sciences and Mary Howard, ElabNYC | ABCT

Sonia Gonzalez, StudentBody

Chad Dyar, Theraputix, Sonia Gonzalez, StudentBody and Mican Meneses, Menopal

Mary Howard, ElabNYC | ABCT and John Bradley, Torreya Partners

Alan Wink, EisnerAmper, , John Bradley, Torreya Partners, Matt McCambridge, Eden Health and Alan Shaw, Sirnaomics

Mary Howard, ElabNYC | ABCT and Nini Fan and Joseph Morin

"Fireside Chat" with Dennis Purcel, Aisling Capital and Alan Roemer, Roivant Sciences

Preparing for Due Diligence workshop, 6.27.19

Michael Osso,Crohn's & Colitis Foundation, Chad Dyar, Theraputix and Nini Fan

Abby Roberts, Merill Corporation and Chouckri Ben Mamoun, eliv5therapeutics

Peikwen Cheng, Yiviva and Craig Kenesky, WSGR

Jordan Frey, EisnerAmper

Barham Marami and Reza Royaee, Dispomeds

Jon Zaikowski, CapCell Biologics and Donal Fishbein, Evolve Therapeutics

Mary Howard, ElabNYC | ABCT and Philip Glick, Conner Strong

Steve O'Loughlin, Actinium Pharmaceuticals and Sue Crinnion, JP Morgan Chase

Raymond Alvarez, Ichor Biologics, Amit Bansal, and Amit Bansal, Digitalis Ventures and Bruce Nemlich, Nemlich BioPharm and Michael Baran, Pfizer Ventures

Preparing for Due Diligence workshop, 6.27.19

Charlotte D'Hulst, Yesse Technologies and Mary Howard

Mary Howard, ElabNYC | ABCT

Chris Barnstable-Brown, WilmerHale, Thjis Spoor, AzurRX BioPharma, Sundeep Bhan, Prognos, Sue Crinnion, JP Morgan Chase and Michael Baran, Pfizer Ventures